mirtazapine has been researched along with Cardiovascular Stroke in 5 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with mirtazapine resulted in a non-significant decrease in betaTG and PF4 and platelet 5-HT levels." | 2.71 | Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. ( Crijns, H; Hamulyák, K; Honig, A; Lousberg, R; Scharpé, S; Schins, A; Van Melle, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tulner, DM | 1 |
| Smith, OR | 1 |
| Schins, A | 3 |
| de Jonge, P | 3 |
| Quere, M | 1 |
| Delanghe, JR | 1 |
| Crijns, HJ | 2 |
| den Boer, JA | 1 |
| Korf, J | 1 |
| Honig, A | 4 |
| Zuidersma, M | 1 |
| Conradi, HJ | 1 |
| van Melle, JP | 3 |
| Ormel, J | 3 |
| van den Brink, RH | 1 |
| Schene, AH | 2 |
| Lambert, FP | 1 |
| Hamulyák, K | 1 |
| Scharpé, S | 1 |
| Lousberg, R | 1 |
| Van Melle, J | 1 |
| Crijns, H | 1 |
| Kuyper, AM | 1 |
| Tulner, D | 1 |
5 trials available for mirtazapine and Cardiovascular Stroke
| Article | Year |
|---|---|
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Inflammation Mediators; M | 2011 |
Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial.
Topics: Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fo | 2013 |
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Follow-Up Studie | 2002 |
Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; CD40 Antigen | 2004 |
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive | 2007 |